secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2023-01-13T23:59:59+00:00
Accession:  0001104659-23-003846
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics increases authorized common shares from 1.2B to 1.7B
------------------------------------------------------------------------------

- Filed Certificate of Amendment with Delaware Secretary of State on January 9, 2023.
- Authorized shares of common stock increased by 500 million to 1.7 billion; par value remains $0.001.
- No concurrent offering or use of proceeds disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/0001104659-23-003846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/tm233422d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-003846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer